ITMCTR2000003504
Not yet recruiting
Phase 1
Clinical study of Traditional Chinese Medicine to Improve the Clinical Benefit Rate of Advanced Esophageal Cancer
Henan Province Hospital of TCM0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Esophageal cancer
- Sponsor
- Henan Province Hospital of TCM
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Meet the diagnostic criteria of Chinese and Western medicine;
- •2\. Esophageal cancer patients who cannot undergo surgery, radiotherapy, chemotherapy or disease progression after chemotherapy;
- •3\. Gender and age are not limited;
- •4\. The estimated survival time was more than 20 days;
- •5\. KPS score \>\= 40;
- •6\. Those who could take traditional Chinese medicine orally before treatment;
- •7\. The patient voluntarily signs the informed consent with the informed consent.
Exclusion Criteria
- •1\. Pregnant and lactating women;
- •2\. Patients with mental illness who are difficult to cooperate with treatment;
- •3\. Allergy to drugs;
- •4\. Patients with severe liver, kidney, heart and hematopoietic system diseases;
- •5\. There was no definite pathological diagnosis;
- •6\. Have participated in other clinical research;
- •7\. According to the researcher's judgment, other diseases or conditions that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in working environment and unstable living environment and other situations that are likely to cause patients to loss to follow\-up.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000002997The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Recruiting
Phase 1
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)novel coronavirus pneumonia (COVID-19)ITMCTR2000003064Affiliated Hospital of Changchun University of traditional Chinese Medicine
Recruiting
Phase 1
Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000003003Shanghai University of TCM
Recruiting
Phase 1
Clinical study of the traditional Chinese medicine wenyangtongluo formula combined with toripalimab plus apatinib and tegio as the third line for advanced gastric cancerStomach cancerITMCTR2200005508Department of Oncology of Integrated Traditional Chinese and Western Medicine, High-tech Campus, First Affiliated Hospital of Anhui
Not yet recruiting
Not Applicable
A clinical study of traditional Chinese medicine combined with western medicine in treatment of primary IgA nephropathy (IgAN) in CKD stage 3ITMCTR2200006488Shanghai east hospital (East Hospital affiliated to Tongji University)